GE HealthCare Technologies Inc (GEHC) concluded trading on Thursday at a closing price of $89.40, with 3.93 million shares of worth about $350.99 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 5.81% during that period and on February 27, 2025 the price saw a loss of about -1.44%. Currently the company’s common shares owned by public are about 456.96M shares, out of which, 455.71M shares are available for trading.
Stock saw a price change of -2.92% in past 5 days and over the past one month there was a price change of 1.85%. Year-to-date (YTD), GEHC shares are showing a performance of 14.35% which decreased to -1.35% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $74.51 but also hit the highest price of $94.80 during that period. The average intraday trading volume for GE HealthCare Technologies Inc shares is 2.81 million. The stock is currently trading -0.20% below its 20-day simple moving average (SMA20), while that difference is up 4.58% for SMA50 and it goes to 6.32% higher than SMA200.
GE HealthCare Technologies Inc (NASDAQ: GEHC) currently have 456.96M outstanding shares and institutions hold larger chunk of about 85.65% of that.
The stock has a current market capitalization of $40.88B and its 3Y-monthly beta is at 1.28. PE ratio of stock for trailing 12 months is 20.59, while it has posted earnings per share of $4.34 in the same period. Its PEG reads 2.31 and has Quick Ratio of 0.79 while making debt-to-equity ratio of 1.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEHC, volatility over the week remained 1.88% while standing at 2.03% over the month.
Stock’s fiscal year EPS is expected to rise by 4.56% while it is estimated to increase by 11.63% in next year. EPS is likely to grow at an annualized rate of 8.91% for next 5-years, compared to annual growth of 5.31% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on January 08, 2025 offering a Buy rating for the stock and assigned a target price range of between $95 and $103 to it. Coverage by UBS stated GE HealthCare Technologies Inc (GEHC) stock as a Sell in their note to investors on September 26, 2024, suggesting a price target of $74 for the stock. On September 18, 2024, BTIG Research Upgrade their recommendations, while on September 09, 2024, JP Morgan Initiated their ratings for the stock with a price target of $90. Stock get a Buy rating from Stifel on August 06, 2024.
